| MOPEE07 | The effect of receiving an oral PrEP delivery model supported with a preferred HIV testing modality on PrEP continuation outcomes: findings from a randomized implementation trial in Kenya | Poster exhibition | Implementation science and scale up of HIV testing |
| MOPEE08 | Familiarity with, perceived accuracy of, and willingness to rely on U=U among Australian gay and bisexual men: results from the PrEPARE Project 2021 | Poster exhibition | Implementation science and scale up of prevention |
| MOPEE09 | Preference heterogeneity among potential users of online pre-exposure prophylaxis provision in Kenya: a discrete choice experiment | Poster exhibition | Implementation science and scale up of prevention |
| MOPEE10 | What men want: preferences for pre-exposure prophylaxis for HIV among men who have sex with men in 16 countries in the Asia-Pacific: a discrete choice experiment | Poster exhibition | Implementation science and scale up of prevention |
| MOPEE11 | Qualitative segmentation of adolescent girls and young women (AGYW) PrEP users: the role of differentiated PrEP delivery platforms | Poster exhibition | Implementation science and scale up of prevention |
| MOPEE12 | Where are the Men? Finding high-risk men through their AGYW sexual partners who are on PrEP in Zambia using HIV prevention indexing | Poster exhibition | Implementation science and scale up of prevention |
| MOPEE13 | Healthcare worker perspectives on anticipated barriers and facilitators to implementing long-acting injectable PrEP for HIV prevention in Vietnam | Poster exhibition | Implementation science and scale up of prevention |
| MOPEE14 | Who chooses event-driven PrEP (PrEP 2-1-1) in a US national cohort? Exploring the role of demographics, wealth, access to health care, sexual behavior and practices on PrEP choice | Poster exhibition | Implementation science and scale up of prevention |
| MOPEE15 | Machine learning models to predict lost to follow-up of people receiving antiretroviral therapy in Brazil, 2014-2022 | Poster exhibition | Implementation science and scale up of treatment |
| MOPEE16 | Preparing for next-generation PrEP: awareness and willingness to use long acting injectable cabotegravir (CAB-LA) among men who have sex with men and trans women across Asia and Australia | Poster exhibition | Implementation science and scale up of prevention |